Learning Objectives
The Institute for Johns Hopkins Nursing takes responsibility for the content, quality, and scientific integrity of this CNE activity. At the conclusion of this activity, participants should be able to:

• Recognize the safety and efficacy features of taxanes, as shown in clinical studies examining breast, lung, and prostate cancer treatment.
• Develop up-to-date and individualized clinical management strategies to maximize the benefit of chemotherapeutic regimens and minimize side effects in patients with cancer.
• Describe the clinical implications of drug administration for breast, lung, and prostate cancer treatment, including dose, schedule/ sequence, and cycle duration.
• Identify potential long-term complications that may arise from adjuvant taxane therapy.
• Implement nursing strategies for in-patient and out-patient settings to prevent, identify, and manage adverse events.

Intended Audience
This activity has been designed to meet the educational needs of oncology nurses and nurse practitioners. There are no prerequisites for attendees.

Accreditation Statement
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Statement of Contact Hours
This 2 contact hour Educational Activity is provided by The Institute for Johns Hopkins Nursing.

Contact hours will be awarded for this Educational Activity until January 15, 2011.

Estimated time to complete this educational activity: 2 hours.

After reviewing this webcast activity, participants may receive credit by completing the CNE test, evaluation, and receiving a score of 70% or higher.

Release date: January 15, 2009. Expiration Date: January 15, 2011.

Accreditation Statement (Nurse Practitioners)
The Institute for Johns Hopkins Nursing is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners: AANP Provider Number 061216.

Statement of Contact Hours (Nurse Practitioners)
This program has been granted 2 contact hours of continuing education (which includes 1 of pharmacology hours).

Commercial Support
Supported by an educational grant from sanofi-aventis U.S.

Non-Endorsement of Products
The Institute for Johns Hopkins Nursing does not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.

Responsibility Statement
The Institute for Johns Hopkins Nursing takes responsibility for the content, quality, and scientific integrity of this CNE activity.

The Institute for Johns Hopkins Nursing Mission Statement
The mission of The Institute for Johns Hopkins Nursing is to share the innovations of Johns Hopkins Nursing in practice, education, and research – locally, nationally, and globally.

Our goal in continuing nursing education is to bring you programs that reflect the expertise and creativity of Johns Hopkins Nursing. Our service values are quality, integrity, flexibility, and personal attentiveness. We appreciate your thoughts and welcome your concerns – please feel free to speak with any IJHN staff member or email us: IJHN@son.jhmi.edu.